▶ 調査レポート

NK細胞療法の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global NK Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。NK細胞療法の世界市場2020年:企業別、地域別、種類・用途別 / Global NK Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / MRC2012B0882資料のイメージです。• レポートコード:MRC2012B0882
• 出版社/出版日:GlobalInfoResearch / 2020年12月24日
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥462,840 (USD3,480)▷ お問い合わせ
  Multi User¥694,260 (USD5,220)▷ お問い合わせ
  Corporate User¥925,680 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、NK細胞療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。NK細胞療法の種類別市場規模(NK細胞療法、NK細胞指向抗体)、用途別市場規模(がん、胃腸疾患、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Nektar Therapeutics、Kiadis Pharma、Chipscreen Biosciences、Innate Pharma SA、Dragonfly Therapeutics、Affimed、Nkarta Therapeutics、Glycostem Therapeutics、Fate Therapeutics、NantWorks、Fortress Biotech、
・地域別グローバル市場分析 2015年-2020年
・NK細胞療法の北米市場(アメリカ、カナダ、メキシコ)
・NK細胞療法のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・NK細胞療法のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・NK細胞療法の南米市場(ブラジル、アルゼンチン)
・NK細胞療法の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:NK細胞療法、NK細胞指向抗体
・用途別分析:がん、胃腸疾患、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The NK Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global NK Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 15.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 466.5 million by 2025, from USD 262.1 million in 2019.

Market segmentation
NK Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, NK Cell Therapy market has been segmented into:
NK Cell Therapies
NK Cell Directed Antibodies

By Application, NK Cell Therapy has been segmented into:
Cancer
Gastrointestinal Diseases
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NK Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level NK Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NK Cell Therapy market.

The report offers in-depth assessment of the growth and other aspects of the NK Cell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and NK Cell Therapy Market Share Analysis
NK Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NK Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NK Cell Therapy sales, revenue and market share for each player covered in this report.

The major players covered in NK Cell Therapy are:
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate Pharma SA
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem Therapeutics
Fate Therapeutics
NantWorks
Fortress Biotech
Among other players domestic and global, NK Cell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 NK Cell Therapy Market Overview
1.1 Product Overview and Scope of NK Cell Therapy
1.2 Classification of NK Cell Therapy by Type
1.2.1 Global NK Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global NK Cell Therapy Revenue Market Share by Type in 2019
1.2.3 NK Cell Therapies
1.2.4 NK Cell Directed Antibodies
1.3 Global NK Cell Therapy Market by Application
1.3.1 Overview: Global NK Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Global NK Cell Therapy Market by Regions
1.4.1 Global NK Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of NK Cell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) NK Cell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) NK Cell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NK Cell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) NK Cell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NK Cell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Nektar Therapeutics
2.1.1 Nektar Therapeutics Details
2.1.2 Nektar Therapeutics Major Business
2.1.3 Nektar Therapeutics SWOT Analysis
2.1.4 Nektar Therapeutics Product and Services
2.1.5 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kiadis Pharma
2.2.1 Kiadis Pharma Details
2.2.2 Kiadis Pharma Major Business
2.2.3 Kiadis Pharma SWOT Analysis
2.2.4 Kiadis Pharma Product and Services
2.2.5 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chipscreen Biosciences
2.3.1 Chipscreen Biosciences Details
2.3.2 Chipscreen Biosciences Major Business
2.3.3 Chipscreen Biosciences SWOT Analysis
2.3.4 Chipscreen Biosciences Product and Services
2.3.5 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Innate Pharma SA
2.4.1 Innate Pharma SA Details
2.4.2 Innate Pharma SA Major Business
2.4.3 Innate Pharma SA SWOT Analysis
2.4.4 Innate Pharma SA Product and Services
2.4.5 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dragonfly Therapeutics
2.5.1 Dragonfly Therapeutics Details
2.5.2 Dragonfly Therapeutics Major Business
2.5.3 Dragonfly Therapeutics SWOT Analysis
2.5.4 Dragonfly Therapeutics Product and Services
2.5.5 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Affimed
2.6.1 Affimed Details
2.6.2 Affimed Major Business
2.6.3 Affimed Product and Services
2.6.4 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nkarta Therapeutics
2.7.1 Nkarta Therapeutics Details
2.7.2 Nkarta Therapeutics Major Business
2.7.3 Nkarta Therapeutics Product and Services
2.7.4 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Glycostem Therapeutics
2.8.1 Glycostem Therapeutics Details
2.8.2 Glycostem Therapeutics Major Business
2.8.3 Glycostem Therapeutics Product and Services
2.8.4 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Fate Therapeutics
2.9.1 Fate Therapeutics Details
2.9.2 Fate Therapeutics Major Business
2.9.3 Fate Therapeutics Product and Services
2.9.4 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 NantWorks
2.10.1 NantWorks Details
2.10.2 NantWorks Major Business
2.10.3 NantWorks Product and Services
2.10.4 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Fortress Biotech
2.11.1 Fortress Biotech Details
2.11.2 Fortress Biotech Major Business
2.11.3 Fortress Biotech Product and Services
2.11.4 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global NK Cell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 NK Cell Therapy Players Market Share
3.2.2 Top 10 NK Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global NK Cell Therapy Revenue and Market Share by Regions
4.2 North America NK Cell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe NK Cell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America NK Cell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa NK Cell Therapy Revenue and Growth Rate (2015-2020)
5 North America NK Cell Therapy Revenue by Countries
5.1 North America NK Cell Therapy Revenue by Countries (2015-2020)
5.2 USA NK Cell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada NK Cell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico NK Cell Therapy Revenue and Growth Rate (2015-2020)
6 Europe NK Cell Therapy Revenue by Countries
6.1 Europe NK Cell Therapy Revenue by Countries (2015-2020)
6.2 Germany NK Cell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK NK Cell Therapy Revenue and Growth Rate (2015-2020)
6.4 France NK Cell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia NK Cell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy NK Cell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific NK Cell Therapy Revenue by Countries
7.1 Asia-Pacific NK Cell Therapy Revenue by Countries (2015-2020)
7.2 China NK Cell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan NK Cell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea NK Cell Therapy Revenue and Growth Rate (2015-2020)
7.5 India NK Cell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia NK Cell Therapy Revenue and Growth Rate (2015-2020)
8 South America NK Cell Therapy Revenue by Countries
8.1 South America NK Cell Therapy Revenue by Countries (2015-2020)
8.2 Brazil NK Cell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina NK Cell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue NK Cell Therapy by Countries
9.1 Middle East & Africa NK Cell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE NK Cell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt NK Cell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa NK Cell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global NK Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global NK Cell Therapy Market Forecast by Type (2019-2024)
10.3 NK Cell Therapies Revenue Growth Rate (2015-2025)
10.4 NK Cell Directed Antibodies Revenue Growth Rate (2015-2025)
11 Global NK Cell Therapy Market Segment by Application
11.1 Global NK Cell Therapy Revenue Market Share by Application (2015-2020)
11.2 NK Cell Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Gastrointestinal Diseases Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global NK Cell Therapy Market Size Forecast (2021-2025)
12.1 Global NK Cell Therapy Market Size Forecast (2021-2025)
12.2 Global NK Cell Therapy Market Forecast by Regions (2021-2025)
12.3 North America NK Cell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe NK Cell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific NK Cell Therapy Revenue Market Forecast (2021-2025)
12.6 South America NK Cell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa NK Cell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global NK Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NK Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NK Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market NK Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global NK Cell Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Nektar Therapeutics Corporate Information, Location and Competitors
Table 7. Nektar Therapeutics NK Cell Therapy Major Business
Table 8. Nektar Therapeutics NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Nektar Therapeutics SWOT Analysis
Table 10. Nektar Therapeutics NK Cell Therapy Product and Solutions
Table 11. Nektar Therapeutics NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Kiadis Pharma Corporate Information, Location and Competitors
Table 13. Kiadis Pharma NK Cell Therapy Major Business
Table 14. Kiadis Pharma NK Cell Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Kiadis Pharma SWOT Analysis
Table 16. Kiadis Pharma NK Cell Therapy Product and Solutions
Table 17. Kiadis Pharma NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Chipscreen Biosciences Corporate Information, Location and Competitors
Table 19. Chipscreen Biosciences NK Cell Therapy Major Business
Table 20. Chipscreen Biosciences NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Chipscreen Biosciences SWOT Analysis
Table 22. Chipscreen Biosciences NK Cell Therapy Product and Solutions
Table 23. Chipscreen Biosciences NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Innate Pharma SA Corporate Information, Location and Competitors
Table 25. Innate Pharma SA NK Cell Therapy Major Business
Table 26. Innate Pharma SA NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Innate Pharma SA SWOT Analysis
Table 28. Innate Pharma SA NK Cell Therapy Product and Solutions
Table 29. Innate Pharma SA NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Dragonfly Therapeutics Corporate Information, Location and Competitors
Table 31. Dragonfly Therapeutics NK Cell Therapy Major Business
Table 32. Dragonfly Therapeutics NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Dragonfly Therapeutics SWOT Analysis
Table 34. Dragonfly Therapeutics NK Cell Therapy Product and Solutions
Table 35. Dragonfly Therapeutics NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Affimed Corporate Information, Location and Competitors
Table 37. Affimed NK Cell Therapy Major Business
Table 38. Affimed NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Affimed SWOT Analysis
Table 40. Affimed NK Cell Therapy Product and Solutions
Table 41. Affimed NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Nkarta Therapeutics Corporate Information, Location and Competitors
Table 43. Nkarta Therapeutics NK Cell Therapy Major Business
Table 44. Nkarta Therapeutics NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Nkarta Therapeutics SWOT Analysis
Table 46. Nkarta Therapeutics NK Cell Therapy Product and Solutions
Table 47. Nkarta Therapeutics NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Glycostem Therapeutics Corporate Information, Location and Competitors
Table 49. Glycostem Therapeutics NK Cell Therapy Major Business
Table 50. Glycostem Therapeutics NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Glycostem Therapeutics SWOT Analysis
Table 52. Glycostem Therapeutics NK Cell Therapy Product and Solutions
Table 53. Glycostem Therapeutics NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Fate Therapeutics Corporate Information, Location and Competitors
Table 55. Fate Therapeutics NK Cell Therapy Major Business
Table 56. Fate Therapeutics NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Fate Therapeutics SWOT Analysis
Table 58. Fate Therapeutics NK Cell Therapy Product and Solutions
Table 59. Fate Therapeutics NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. NantWorks Corporate Information, Location and Competitors
Table 61. NantWorks NK Cell Therapy Major Business
Table 62. NantWorks NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 63. NantWorks SWOT Analysis
Table 64. NantWorks NK Cell Therapy Product and Solutions
Table 65. NantWorks NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Fortress Biotech Corporate Information, Location and Competitors
Table 67. Fortress Biotech NK Cell Therapy Major Business
Table 68. Fortress Biotech NK Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 69. Fortress Biotech SWOT Analysis
Table 70. Fortress Biotech NK Cell Therapy Product and Solutions
Table 71. Fortress Biotech NK Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global NK Cell Therapy Revenue (Million USD) by Players (2015-2020)
Table 73. Global NK Cell Therapy Revenue Share by Players (2015-2020)
Table 74. Global NK Cell Therapy Revenue (Million USD) by Regions (2015-2020)
Table 75. Global NK Cell Therapy Revenue Market Share by Regions (2015-2020)
Table 76. North America NK Cell Therapy Revenue by Countries (2015-2020)
Table 77. North America NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 78. Europe NK Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific NK Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 80. South America NK Cell Therapy Revenue by Countries (2015-2020)
Table 81. South America NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa NK Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 84. Global NK Cell Therapy Revenue (Million USD) by Type (2015-2020)
Table 85. Global NK Cell Therapy Revenue Share by Type (2015-2020)
Table 86. Global NK Cell Therapy Revenue Forecast by Type (2021-2025)
Table 87. Global NK Cell Therapy Revenue by Application (2015-2020)
Table 88. Global NK Cell Therapy Revenue Share by Application (2015-2020)
Table 89. Global NK Cell Therapy Revenue Forecast by Application (2021-2025)
Table 90. Global NK Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. NK Cell Therapy Picture
Figure 2. Global NK Cell Therapy Revenue Market Share by Type in 2019
Figure 3. NK Cell Therapies Picture
Figure 4. NK Cell Directed Antibodies Picture
Figure 5. NK Cell Therapy Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Gastrointestinal Diseases Picture
Figure 8. Others Picture
Figure 9. Global NK Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America NK Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe NK Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific NK Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America NK Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa NK Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global NK Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global NK Cell Therapy Revenue Share by Players in 2019
Figure 17. Global Top 5 Players NK Cell Therapy Revenue Market Share in 2019
Figure 18. Global Top 10 Players NK Cell Therapy Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global NK Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global NK Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure 22. Global NK Cell Therapy Revenue Market Share by Regions in 2018
Figure 23. North America NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 24. Europe NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 26. South America NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 28. North America NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 29. North America NK Cell Therapy Revenue Market Share by Countries in 2019
Figure 30. USA NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 31. Canada NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Mexico NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Europe NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 34. Europe NK Cell Therapy Revenue Market Share by Countries in 2019
Figure 35. Germany NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 36. UK NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 37. France NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 38. Russia NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Italy NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific NK Cell Therapy Revenue Market Share by Countries in 2019
Figure 42. China NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 43. Japan NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Korea NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 45. India NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 47. South America NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 48. South America NK Cell Therapy Revenue Market Share by Countries in 2019
Figure 49. Brazil NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 50. Argentina NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa NK Cell Therapy Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 54. UAE NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 55. Egypt NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 56. South Africa NK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Global NK Cell Therapy Revenue Share by Type (2015-2020)
Figure 58. Global NK Cell Therapy Revenue Share by Type in 2019
Figure 59. Global NK Cell Therapy Market Share Forecast by Type (2021-2025)
Figure 60. Global NK Cell Therapies Revenue Growth Rate (2015-2020)
Figure 61. Global NK Cell Directed Antibodies Revenue Growth Rate (2015-2020)
Figure 62. Global NK Cell Therapy Revenue Share by Application (2015-2020)
Figure 63. Global NK Cell Therapy Revenue Share by Application in 2019
Figure 64. Global NK Cell Therapy Market Share Forecast by Application (2021-2025)
Figure 65. Global Cancer Revenue Growth Rate (2015-2020)
Figure 66. Global Gastrointestinal Diseases Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global NK Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global NK Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global NK Cell Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America NK Cell Therapy Revenue Market Forecast (2021-2025)
Figure 72. Europe NK Cell Therapy Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific NK Cell Therapy Revenue Market Forecast (2021-2025)
Figure 74. South America NK Cell Therapy Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa NK Cell Therapy Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel